A retrospective cohort study assessing the primary prophylactic patterns of granulocyte colony–stimulating factor (G-CSF) use after chemotherapy by cancer type and febrile neutropenia risk
Latest Information Update: 30 Sep 2020
At a glance
- Drugs Filgrastim (Primary) ; Pegfilgrastim (Primary)
- Indications Chemotherapy-induced damage; Febrile neutropenia
- Focus Therapeutic Use
- 30 Sep 2020 New trial record
- 01 Sep 2020 Results published in the Supportive Care in Cancer